{
  "zip": "46038",
  "sector": "Healthcare",
  "longBusinessSummary": "Acro Biomedical Co., Ltd. develops and markets nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine; and metallothionein MT-3 elizer, a protein powder used in health supplements. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was founded in 2014 and is based in Fishers, Indiana.",
  "city": "Fishers",
  "phone": "317 286 6788",
  "state": "IN",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://acrobiomedicalco.com",
  "maxAge": 1,
  "address1": "2175 Visionary Way",
  "industry": "Biotechnology",
  "address2": "Suite 1160",
  "previousClose": 3.75,
  "regularMarketOpen": 3.875,
  "twoHundredDayAverage": 3.868,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 3.75,
  "navPrice": null,
  "averageDailyVolume10Day": 540,
  "totalAssets": null,
  "regularMarketPreviousClose": 3.75,
  "fiftyDayAverage": 3.868,
  "trailingAnnualDividendRate": null,
  "open": 3.875,
  "averageVolume10days": 540,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.848364,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 3.75,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 750,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 179100000,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 540,
  "priceToSalesTrailing12Months": 122.49437,
  "dayLow": 3.75,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 750,
  "fiftyTwoWeekHigh": 3.975,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 3.75,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 3.75,
  "exchange": "PNK",
  "shortName": "ACRO BIOMEDICAL CO LTD",
  "longName": "Acro Biomedical Co., Ltd.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ACBM",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_275278187",
  "uuid": "d23fd98b-44b4-3095-98b0-1131a06280de",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 122.644,
  "beta3Year": null,
  "profitMargins": -0.043390002,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 47760000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.016,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -63443,
  "trailingEps": -0.001,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 234.37498,
  "heldPercentInsiders": 0.62814,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 17760034,
  "enterpriseValue": 179318400,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 3.875,
  "logo_url": "https://logo.clearbit.com/acrobiomedicalco.com"
}